Ceva has announced its financial results for the 2017 business year, during which the firm achieved double-digit growth and a record-breaking overall performance.
The company generated sales of EUR 1.1 billion (GBP 972.93 million) for the year - the first time the firm has passed the EUR 1 billion mark in annual sales - following a 20 percent year-on-year revenue increase.
“Ceva surpassed the EUR 1 billion mark in annual sales for the first time in 2017.“
Its swine business recorded the biggest increase, with sales up by 66 percent following the recent acquisition of four vaccine products from Merial. Ruminants sales were also up by 40 percent, thanks to the purchase of the Brazilian firms Hertape and Inova.
In 2018, the company will open three new facilities in France as it seeks to strengthen its position as the sixth-largest animal health company in the world. It will also invest in emerging fields such as AI, connected agriculture, robotisation, digitalisation and big data.
Dr Marc Prikazsky, Ceva's chairman and chief executive officer, said: "This is a challenge for the agricultural community as a whole, both in France and around the world. In all these areas, once again, Ceva wants to become a first-line reference."
With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.See all the latest jobs in Animal Health